PDF herunterladen
Semin Respir Crit Care Med 2021; 42(03): 449-459
DOI: 10.1055/s-0041-1729172
Review Article

Community-Acquired Respiratory Viruses Post–Lung Transplant

Stuart C. Sweet
1   Division of Allergy and Pulmonary Medicine, Washington University in St. Louis, St. Louis, Missouri
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Survival in lung transplant recipients (LTRs) lags behind heart, liver, and kidney transplant, in part due to the direct and indirect effects of infection. LTRs have increased susceptibility to infection due to the combination of a graft continually exposed to the outside world, multiple mechanisms for impaired mucus clearance, and immunosuppression. Community-acquired respiratory viral infections (CARVs) are common in LTRs. Picornaviruses have roughly 40% cumulative incidence followed by respiratory syncytial virus and coronaviruses. Although single-center retrospective and prospective series implicate CARV in rejection and mortality, conclusive evidence for and well-defined mechanistic links to long-term outcome are lacking. Treatment of viral infections can be challenging except for influenza. Future studies are needed to develop better treatments and clarify the links between CARV and long-term outcomes.

Keywords

lung transplantation - lung allograft rejection - influenza - respiratory syncytial virus - adenovirus - parainfluenza


Publikationsverlauf

Artikel online veröffentlicht:
24. Mai 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Chambers DC, Cherikh WS, Harhay MO. et al; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Sixth Adult Lung and Heart-Lung Transplantation Report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019; 38 (10) 1042-1055
    CrossrefPubMedGoogle Scholar
  • 2 Hayes Jr D, Cherikh WS, Chambers DC. et al; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-Second Pediatric Lung and Heart-Lung Transplantation Report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019; 38 (10) 1015-1027
    CrossrefPubMedGoogle Scholar
  • 3 Cooper JD, Billingham M, Egan T. et al; International Society for Heart and Lung Transplantation. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12 (05) 713-716
    PubMedGoogle Scholar
  • 4 Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166 (04) 440-444
    CrossrefPubMedGoogle Scholar
  • 5 Sato M, Waddell TK, Wagnetz U. et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30 (07) 735-742
    CrossrefPubMedGoogle Scholar
  • 6 Verleden GM, Glanville AR, Lease ED. et al. Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment—a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant 2019; 38 (05) 493-503
    CrossrefPubMedGoogle Scholar
  • 7 Alexander BD, Tapson VF. Infectious complications of lung transplantation. Transpl Infect Dis 2001; 3 (03) 128-137
    CrossrefPubMedGoogle Scholar
  • 8 Verleden GM, Vos R, van Raemdonck D, Vanaudenaerde B. Pulmonary infection defense after lung transplantation: does airway ischemia play a role?. Curr Opin Organ Transplant 2010; 15 (05) 568-571
    CrossrefPubMedGoogle Scholar
  • 9 Witt CA, Meyers BF, Hachem RR. Pulmonary infections following lung transplantation. Thorac Surg Clin 2012; 22 (03) 403-412
    CrossrefPubMedGoogle Scholar
  • 10 Nørgaard MAB, Andersen CB, Pettersson G. Airway epithelium of transplanted lungs with and without direct bronchial artery revascularization. Eur J Cardiothorac Surg 1999; 15 (01) 37-44
    CrossrefPubMedGoogle Scholar
  • 11 Duarte AG, Myers AC. Cough reflex in lung transplant recipients. Lung 2012; 190 (01) 23-27
    CrossrefPubMedGoogle Scholar
  • 12 Speich R, van der Bij W. Epidemiology and management of infections after lung transplantation. Clin Infect Dis 2001; 33 (Suppl. 01) S58-S65
    CrossrefPubMedGoogle Scholar
  • 13 Herve P, Silbert D, Cerrina J, Simonneau G, Dartevelle P. The Paris-Sud Lung Transplant Group. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. Chest 1993; 103 (01) 59-63
    CrossrefPubMedGoogle Scholar
  • 14 Read RC, Shankar S, Rutman A. et al. Ciliary beat frequency and structure of recipient and donor epithelia following lung transplantation. Eur Respir J 1991; 4 (07) 796-801
    CrossrefPubMedGoogle Scholar
  • 15 Veale D, Glasper PN, Gascoigne A, Dark JH, Gibson GJ, Corris PA. Ciliary beat frequency in transplanted lungs. Thorax 1993; 48 (06) 629-631
    CrossrefPubMedGoogle Scholar
  • 16 Burguete SR, Maselli DJ, Fernandez JF, Levine SM. Lung transplant infection. Respirology 2013; 18 (01) 22-38
    CrossrefPubMedGoogle Scholar
  • 17 Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998; 114 (05) 1411-1426
    CrossrefPubMedGoogle Scholar
  • 18 Fischer SA, Avery RK. AST Infectious Disease Community of Practice. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009; 9 (Suppl. 04) S7-S18
    CrossrefPubMedGoogle Scholar
  • 19 Humar A, Michaels M. AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6 (02) 262-274
    CrossrefPubMedGoogle Scholar
  • 20 Subbarao K, Mahanty S. Respiratory virus infections: understanding COVID-19. Immunity 2020; 52 (06) 905-909
    CrossrefPubMedGoogle Scholar
  • 21 Abedi A, Hall R, Levine DJ. Respiratory Viruses and Other Relevant Viral Infections in the Lung Transplant Recipient. Springer International Publishing; 2018: 241-262
    Google Scholar
  • 22 Mombelli M, Lang BM, Neofytos D. et al; Swiss Transplant Cohort Study. Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study. Am J Transplant 2020; ; (epub ahead of print) DOI: 10.1111/ajt.16383.
    CrossrefPubMedGoogle Scholar
  • 23 Sweet SC, Chin H, Conrad C. et al. Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: results of the CTOTC-03 study. Am J Transplant 2019; 19 (12) 3284-3298
    CrossrefPubMedGoogle Scholar
  • 24 Vu DL, Bridevaux PO, Aubert JD, Soccal PM, Kaiser L. Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies. Am J Transplant 2011; 11 (05) 1071-1078
    CrossrefPubMedGoogle Scholar
  • 25 Apalsch AM, Green M, Ledesma-Medina J, Nour B, Wald ER. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20 (02) 394-399
    CrossrefPubMedGoogle Scholar
  • 26 Holt ND, Gould FK, Taylor CE. et al. Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation. J Heart Lung Transplant 1997; 16 (04) 416-419
    PubMedGoogle Scholar
  • 27 Palmer Jr SM, Henshaw NG, Howell DN, Miller SE, Davis RD, Tapson VF. Community respiratory viral infection in adult lung transplant recipients. Chest 1998; 113 (04) 944-950
    CrossrefPubMedGoogle Scholar
  • 28 Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 1998; 116 (04) 617-623
    CrossrefPubMedGoogle Scholar
  • 29 Krinzman S, Basgoz N, Kradin R. et al. Respiratory syncytial virus-associated infections in adult recipients of solid organ transplants. J Heart Lung Transplant 1998; 17 (02) 202-210
    PubMedGoogle Scholar
  • 30 Vilchez RA, McCurry K, Dauber J. et al. The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 2001; 33 (12) 2004-2008
    CrossrefPubMedGoogle Scholar
  • 31 Garantziotis S, Howell DN, McAdams HP, Davis RD, Henshaw NG, Palmer SM. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 2001; 119 (04) 1277-1280
    CrossrefPubMedGoogle Scholar
  • 32 Weinberg A, Zamora MR, Li S, Torres F, Hodges TN. The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients. J Clin Virol 2002; 25 (02) 171-175
    CrossrefPubMedGoogle Scholar
  • 33 Vilchez R, McCurry K, Dauber J. et al. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 2002; 73 (07) 1075-1078
    CrossrefPubMedGoogle Scholar
  • 34 Billings JL, Hertz MI, Savik K, Wendt CH. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 2002; 21 (05) 559-566
    CrossrefPubMedGoogle Scholar
  • 35 Vilchez RA, McCurry K, Dauber J. et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2 (03) 287-291
    CrossrefPubMedGoogle Scholar
  • 36 Hopkins PM, Plit ML, Carter IW, Chhajed PN, Malouf MA, Glanville AR. Indirect fluorescent antibody testing of nasopharyngeal swabs for influenza diagnosis in lung transplant recipients. J Heart Lung Transplant 2003; 22 (02) 161-168
    CrossrefPubMedGoogle Scholar
  • 37 McCurdy LH, Milstone A, Dummer S. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. J Heart Lung Transplant 2003; 22 (07) 745-753
    CrossrefPubMedGoogle Scholar
  • 38 Khalifah AP, Hachem RR, Chakinala MM. et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004; 170 (02) 181-187
    CrossrefPubMedGoogle Scholar
  • 39 Garbino J, Gerbase MW, Wunderli W. et al. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients. Chest 2004; 125 (03) 1033-1039
    CrossrefPubMedGoogle Scholar
  • 40 Garbino J, Gerbase MW, Wunderli W. et al. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med 2004; 170 (11) 1197-1203
    CrossrefPubMedGoogle Scholar
  • 41 Sumino KC, Agapov E, Pierce RA. et al. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis 2005; 192 (06) 1052-1060
    CrossrefPubMedGoogle Scholar
  • 42 Larcher C, Geltner C, Fischer H, Nachbaur D, Müller LC, Huemer HP. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 2005; 24 (11) 1891-1901
    CrossrefPubMedGoogle Scholar
  • 43 Kumar D, Erdman D, Keshavjee S. et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 5 (08) 2031-2036
    CrossrefPubMedGoogle Scholar
  • 44 Glanville AR, Scott AI, Morton JM. et al. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2005; 24 (12) 2114-2119
    CrossrefPubMedGoogle Scholar
  • 45 Milstone AP, Brumble LM, Barnes J. et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006; 28 (01) 131-137
    CrossrefPubMedGoogle Scholar
  • 46 Gerna G, Vitulo P, Rovida F. et al. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol 2006; 78 (03) 408-416
    CrossrefPubMedGoogle Scholar
  • 47 Dare R, Sanghavi S, Bullotta A. et al. Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol 2007; 45 (02) 548-552
    CrossrefPubMedGoogle Scholar
  • 48 Hopkins P, McNeil K, Kermeen F. et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008; 178 (08) 876-881
    CrossrefPubMedGoogle Scholar
  • 49 Miyakis S, van Hal SJ, Barratt J, Stark D, Marriott D, Harkness J. Absence of human bocavirus in bronchoalveolar lavage fluid of lung transplant patients. J Clin Virol 2009; 44 (02) 179-180
    CrossrefPubMedGoogle Scholar
  • 50 Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC. Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant 2008; 27 (03) 282-288
    CrossrefPubMedGoogle Scholar
  • 51 Soccal PM, Aubert JD, Bridevaux PO. et al. Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients. Clin Infect Dis 2010; 51 (02) 163-170
    CrossrefPubMedGoogle Scholar
  • 52 Gottlieb J, Schulz TF, Welte T. et al. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 2009; 87 (10) 1530-1537
    CrossrefPubMedGoogle Scholar
  • 53 Gerna G, Piralla A, Rovida F. et al. Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. J Med Virol 2009; 81 (08) 1498-1507
    CrossrefPubMedGoogle Scholar
  • 54 Liu M, Worley S, Arrigain S. et al. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis 2009; 11 (04) 304-312
    CrossrefPubMedGoogle Scholar
  • 55 Costa C, Bergallo M, Sidoti F. et al. What role for human rhinoviruses in the lower respiratory tract?. New Microbiol 2009; 32 (01) 115-117
    PubMedGoogle Scholar
  • 56 Pelaez A, Lyon GM, Force SD. et al. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant 2009; 28 (01) 67-71
    CrossrefPubMedGoogle Scholar
  • 57 Liu V, Dhillon GS, Weill D. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Transpl Infect Dis 2010; 12 (01) 38-44
    CrossrefPubMedGoogle Scholar
  • 58 Kumar D, Husain S, Chen MH. et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation 2010; 89 (08) 1028-1033
    CrossrefPubMedGoogle Scholar
  • 59 Bailey ES, Zemke JN, Choi JY, Gray GC. A mini-review of adverse lung transplant outcomes associated with respiratory viruses. Front Immunol 2019; 10: 2861
    CrossrefPubMedGoogle Scholar
  • 60 Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med 1993; 153 (17) 2010-2016
    CrossrefPubMedGoogle Scholar
  • 61 Ohori NP, Michaels MG, Jaffe R, Williams P, Yousem SA. Adenovirus pneumonia in lung transplant recipients. Hum Pathol 1995; 26 (10) 1073-1079
    CrossrefPubMedGoogle Scholar
  • 62 Riise GC, Kjellström C, Ryd W. et al. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study. Eur Respir J 1997; 10 (08) 1742-1746
    CrossrefPubMedGoogle Scholar
  • 63 Humar A, Doucette K, Kumar D. et al. Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance. J Heart Lung Transplant 2006; 25 (12) 1441-1446
    CrossrefPubMedGoogle Scholar
  • 64 Kaiser L, Aubert JD, Pache JC. et al. Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med 2006; 174 (12) 1392-1399
    CrossrefPubMedGoogle Scholar
  • 65 Engelmann I, Welte T, Fühner T. et al. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. J Clin Virol 2009; 45 (01) 47-53
    CrossrefPubMedGoogle Scholar
  • 66 Bergallo M, Costa C, Terlizzi ME. et al. Quantitative detection of the new polyomaviruses KI, WU and Merkel cell virus in transbronchial biopsies from lung transplant recipients. J Clin Pathol 2010; 63 (08) 722-725
    CrossrefPubMedGoogle Scholar
  • 67 Uçkay I, Gasche-Soccal PM, Kaiser L. et al. Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy. J Heart Lung Transplant 2010; 29 (03) 299-305
    CrossrefPubMedGoogle Scholar
  • 68 Weinberg A, Lyu DM, Li S, Marquesen J, Zamora MR. Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients. Transpl Infect Dis 2010; 12 (04) 330-335
    CrossrefPubMedGoogle Scholar
  • 69 Ng BJ, Glanville AR, Snell G. et al. The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients. Am J Transplant 2011; 11 (03) 568-574
    CrossrefPubMedGoogle Scholar
  • 70 Ariza-Heredia EJ, Fishman JE, Cleary T, Smith L, Razonable RR, Abbo L. Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience. Transpl Infect Dis 2012; 14 (01) 64-71
    CrossrefPubMedGoogle Scholar
  • 71 Li L, Avery R, Budev M, Mossad S, Danziger-Isakov L. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2012; 31 (08) 839-844
    CrossrefPubMedGoogle Scholar
  • 72 Lo MS, Lee GM, Gunawardane N, Burchett SK, Lachenauer CS, Lehmann LE. The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant 2013; 17 (02) 133-143
    CrossrefPubMedGoogle Scholar
  • 73 Sayah DM, Koff JL, Leard LE, Hays SR, Golden JA, Singer JP. Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection. Clin Transplant 2013; 27 (01) E64-E71
    CrossrefPubMedGoogle Scholar
  • 74 Bridevaux PO, Aubert JD, Soccal PM. et al. Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax 2014; 69 (01) 32-38
    CrossrefPubMedGoogle Scholar
  • 75 Schuurmans MM, Isenring BD, Jungo C. et al. Clinical features and outcomes of influenza infections in lung transplant recipients: a single-season cohort study. Transpl Infect Dis 2014; 16 (03) 430-439
    CrossrefPubMedGoogle Scholar
  • 76 Tabarelli W, Bonatti H, Tabarelli D. et al. Long term complications following 54 consecutive lung transplants. J Thorac Dis 2016; 8 (06) 1234-1244
    CrossrefPubMedGoogle Scholar
  • 77 Peghin M, Hirsch HH, Len Ó. et al. Epidemiology and immediate indirect effects of respiratory viruses in lung transplant recipients: a 5-year prospective study. Am J Transplant 2017; 17 (05) 1304-1312
    CrossrefPubMedGoogle Scholar
  • 78 Liu M, Mallory GB, Schecter MG. et al. Long-term impact of respiratory viral infection after pediatric lung transplantation. Pediatr Transplant 2010; 14 (03) 431-436
    CrossrefPubMedGoogle Scholar
  • 79 Matar LD, McAdams HP, Palmer SM. et al. Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. Radiology 1999; 213 (03) 735-742
    CrossrefPubMedGoogle Scholar
  • 80 Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002; 21 (02) 271-281
    CrossrefPubMedGoogle Scholar
  • 81 Fisher CE, Preiksaitis CM, Lease ED. et al. Symptomatic respiratory virus infection and chronic lung allograft dysfunction. Clin Infect Dis 2016; 62 (03) 313-319
    CrossrefPubMedGoogle Scholar
  • 82 Allyn PR, Duffy EL, Humphries RM. et al. Graft loss and CLAD-onset is hastened by viral pneumonia after lung transplantation. Transplantation 2016; 100 (11) 2424-2431
    CrossrefPubMedGoogle Scholar
  • 83 Magnusson J, Westin J, Andersson LM. et al. Viral respiratory tract infection during the first postoperative year is a risk factor for chronic rejection after lung transplantation. Transplant Direct 2018; 4 (08) e370
    CrossrefPubMedGoogle Scholar
  • 84 Peghin M, Los-Arcos I, Hirsch HH. et al. Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction. Clin Infect Dis 2019; 69 (07) 1192-1197
    CrossrefPubMedGoogle Scholar
  • 85 Hohlfeld J, Niedermeyer J, Hamm H, Schäfers HJ, Wagner TO, Fabel H. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 1996; 15 (09) 888-894
    PubMedGoogle Scholar
  • 86 Henrickson KJ, Hoover S, Kehl KS, Hua W. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J 2004; 23 (1, Suppl): S11-S18
    CrossrefPubMedGoogle Scholar
  • 87 Arslan D, Danziger-Isakov L. Respiratory viral infections in pediatric solid organ and hematopoietic stem cell transplantation. Curr Infect Dis Rep 2012; 14 (06) 658-667
    CrossrefPubMedGoogle Scholar
  • 88 Krunic N, Yager TD, Himsworth D, Merante F, Yaghoubian S, Janeczko R. xTAG RVP assay: analytical and clinical performance. J Clin Virol 2007; 40 (Suppl. 01) S39-S46
    CrossrefPubMedGoogle Scholar
  • 89 Mahony JB. Nucleic acid amplification-based diagnosis of respiratory virus infections. Expert Rev Anti Infect Ther 2010; 8 (11) 1273-1292
    CrossrefPubMedGoogle Scholar
  • 90 Kuypers J, Campbell AP, Cent A, Corey L, Boeckh M. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis 2009; 11 (04) 298-303
    CrossrefPubMedGoogle Scholar
  • 91 Balada-Llasat JM, LaRue H, Kelly C, Rigali L, Pancholi P. Evaluation of commercial ResPlex II v2.0, MultiCode-PLx, and xTAG respiratory viral panels for the diagnosis of respiratory viral infections in adults. J Clin Virol 2011; 50 (01) 42-45
    CrossrefPubMedGoogle Scholar
  • 92 Berry M, Gamieldien J, Fielding BC. Identification of new respiratory viruses in the new millennium. Viruses 2015; 7 (03) 996-1019
    CrossrefPubMedGoogle Scholar
  • 93 Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis 2011; 52 (Suppl. 04) S284-S289
    CrossrefPubMedGoogle Scholar
  • 94 Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med 1985; 78 (6B): 32-37
    CrossrefPubMedGoogle Scholar
  • 95 Chakinala MM, Walter MJ. Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences. Semin Thorac Cardiovasc Surg 2004; 16 (04) 342-349
    CrossrefPubMedGoogle Scholar
  • 96 Billings JL, Hertz MI, Wendt CH. Community respiratory virus infections following lung transplantation. Transpl Infect Dis 2001; 3 (03) 138-148
    CrossrefPubMedGoogle Scholar
  • 97 Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007; 28 (02) 222-242
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 98 Manuel O, Estabrook M. American Society of Transplantation Infectious Diseases Community of Practice. RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33 (09) e13511
    CrossrefPubMedGoogle Scholar
  • 99 Wendt CH, Fox JM, Hertz MI. Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant 1995; 14 (03) 479-485
    PubMedGoogle Scholar
  • 100 Wendt CH. Community respiratory viruses: organ transplant recipients. Am J Med 1997; 102 (3A): 31-36, discussion 42–43
    CrossrefPubMedGoogle Scholar
  • 101 Hynicka LM, Ensor CR. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients. Ann Pharmacother 2012; 46 (04) 558-566
    CrossrefPubMedGoogle Scholar
  • 102 Gottlieb J, Zamora MR, Hodges T. et al. ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients. J Heart Lung Transplant 2016; 35 (02) 213-221
    CrossrefPubMedGoogle Scholar
  • 103 Chemaly RF, Dadwal SS, Bergeron A. et al. A Phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients. Clin Infect Dis 2020; 71 (11) 2777-2786
    CrossrefPubMedGoogle Scholar
  • 104 Vilchez RA, Dauber J, McCurry K, Iacono A, Kusne S. Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function. [Review] Am J Transplant 2003; 3 (02) 116-120
    CrossrefPubMedGoogle Scholar
  • 105 Salvatore M, Satlin MJ, Jacobs SE. et al. DAS181 for treatment of parainfluenza virus infections in hematopoietic stem cell transplant recipients at a single center. Biol Blood Marrow Transplant 2016; 22 (05) 965-970
    CrossrefPubMedGoogle Scholar
  • 106 Drozd DR, Limaye AP, Moss RB. et al. DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient. Transpl Infect Dis 2013; 15 (01) E28-E32
    CrossrefPubMedGoogle Scholar
  • 107 Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study. Accessed April 3, 2021 at: https://clinicaltrials.gov/ct2/show/NCT03808922
    PubMedGoogle Scholar
  • 108 Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43 (03) 331-339
    CrossrefPubMedGoogle Scholar
  • 109 Florescu DF, Hoffman JA. AST Infectious Diseases Community of Practice. Adenovirus in solid organ transplantation. Am J Transplant 2013; 13 (Suppl. 04) 206-211
    CrossrefPubMedGoogle Scholar
  • 110 Philo SE, Anderson BD, Costa SF. et al. Adenovirus type 21 outbreak among lung transplant patients at a large tertiary care hospital. Open Forum Infect Dis 2018; 5 (08) ofy188
    CrossrefPubMedGoogle Scholar
  • 111 Phase III Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection (CMX001 Adv). Accessed April 3, 2021 at: https://clinicaltrials.gov/ct2/show/NCT02087306
    PubMedGoogle Scholar
  • 112 Pereira MR, Mohan S, Cohen DJ. et al. COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant 2020; 20 (07) 1800-1808
    CrossrefPubMedGoogle Scholar
  • 113 Saez-Giménez B, Berastegui C, Barrecheguren M. et al. COVID-19 in lung transplant recipients: a multicenter study. Am J Transplant 2020; ; (epub ahead of print) DOI: 10.1111/ajt.16364.
    CrossrefPubMedGoogle Scholar
  • 114 Messika J, Eloy P, Roux A. et al; French Group of Lung Transplantation. COVID-19 in lung transplant recipients. Transplantation 2021; 105 (01) 177-186
    CrossrefPubMedGoogle Scholar
  • 115 Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Accessed April 3, 2021 at: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/
    PubMedGoogle Scholar
  • 116 Tripp RA, Oshansky C, Alvarez R. Cytokines and respiratory syncytial virus infection. Proc Am Thorac Soc 2005; 2 (02) 147-149
    CrossrefPubMedGoogle Scholar
  • 117 Schaller M, Hogaboam CM, Lukacs N, Kunkel SL. Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response. J Allergy Clin Immunol 2006; 118 (02) 295-302 , quiz 303–304
    CrossrefPubMedGoogle Scholar
  • 118 Braciale TJ. Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system. Proc Am Thorac Soc 2005; 2 (02) 141-146
    CrossrefPubMedGoogle Scholar
  • 119 Colvin BL, Thomson AW. Chemokines, their receptors, and transplant outcome. Transplantation 2002; 74 (02) 149-155
    CrossrefPubMedGoogle Scholar
  • 120 Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344 (25) 1917-1928
    CrossrefPubMedGoogle Scholar
  • 121 Skoner DP, Gentile DA, Patel A, Doyle WJ. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis 1999; 180 (01) 10-14
    CrossrefPubMedGoogle Scholar
  • 122 Arnold R, Humbert B, Werchau H, Gallati H, König W. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1994; 82 (01) 126-133
    PubMedGoogle Scholar
  • 123 Matsukura S, Kokubu F, Noda H, Tokunaga H, Adachi M. Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 1996; 98 (6, Pt 1): 1080-1087
    CrossrefPubMedGoogle Scholar
  • 124 Bruder JT, Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 1997; 71 (01) 398-404
    CrossrefPubMedGoogle Scholar
  • 125 Karp CL, Wysocka M, Wahl LM. et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996; 273 (5272): 228-231
    CrossrefPubMedGoogle Scholar
  • 126 Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995; 96 (01) 549-557
    CrossrefPubMedGoogle Scholar
  • 127 Kohlmeier JE, Cookenham T, Miller SC. et al. CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection. J Immunol 2009; 183 (07) 4378-4384
    CrossrefPubMedGoogle Scholar
  • 128 Lindell DM, Lane TE, Lukacs NW. CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy. Eur J Immunol 2008; 38 (08) 2168-2179
    CrossrefPubMedGoogle Scholar
  • 129 Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol 2004; 76 (04) 886-895
    CrossrefPubMedGoogle Scholar
  • 130 Belperio JA, Keane MP, Burdick MD. et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002; 169 (02) 1037-1049
    CrossrefPubMedGoogle Scholar
  • 131 Belperio JA, Keane MP, Burdick MD. et al. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 2003; 171 (09) 4844-4852
    CrossrefPubMedGoogle Scholar
  • 132 Medoff BD, Wain JC, Seung E. et al. CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function. J Immunol 2006; 176 (11) 7087-7095
    CrossrefPubMedGoogle Scholar
  • 133 Weigt SS, Derhovanessian A, Liao E. et al. CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction. Am J Transplant 2012; 12 (02) 477-484
    CrossrefPubMedGoogle Scholar
  • 134 Chalermskulrat W, Neuringer IP, Schmitz JL. et al. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chest 2003; 123 (06) 1825-1831
    CrossrefPubMedGoogle Scholar
  • 135 Saini D, Weber J, Ramachandran S. et al. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant 2011; 30 (06) 624-631
    CrossrefPubMedGoogle Scholar
  • 136 Brugière O, Roux A, Le Pavec J. et al. Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome. Eur Respir J 2018; 52 (02) 1701898
    CrossrefPubMedGoogle Scholar
  • 137 Brugière O, Suberbielle C, Thabut G. et al. Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay. Transplantation 2013; 95 (05) 761-765
    CrossrefPubMedGoogle Scholar
  • 138 Bharat A, Saini D, Steward N. et al. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg 2010; 90 (04) 1094-1101
    CrossrefPubMedGoogle Scholar
  • 139 Goers TA, Ramachandran S, Aloush A, Trulock E, Patterson GA, Mohanakumar T. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 2008; 180 (07) 4487-4494
    CrossrefPubMedGoogle Scholar
  • 140 Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T. Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant 2012; 12 (08) 2164-2171
    CrossrefPubMedGoogle Scholar
  • 141 Gunasekaran M, Xu Z, Nayak DK. et al. Donor-derived exosomes with lung self-antigens in human lung allograft rejection. Am J Transplant 2017; 17 (02) 474-484
    CrossrefPubMedGoogle Scholar
  • 142 Sharma M, Ravichandran R, Perincheri S. et al. Distinct molecular and immunological properties of circulating exosomes isolated from pediatric lung transplant recipients with bronchiolitis obliterans syndrome - a retrospective study. Transpl Int 2020; 33 (11) 1491-1502
    CrossrefPubMedGoogle Scholar
  • 143 Gunasekaran M, Bansal S, Ravichandran R. et al. Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection. J Heart Lung Transplant 2020; 39 (04) 379-388
    CrossrefPubMedGoogle Scholar